These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High activity of low-Michaelis-Menten constant 3', 5'-cyclic adenosine monophosphate-phosphodiesterase isozymes in renal inner medulla of mice with hereditary nephrogenic diabetes insipidus. Takeda S; Lin CT; Morgano PG; McIntyre SJ; Dousa TP Endocrinology; 1991 Jul; 129(1):287-94. PubMed ID: 1647298 [TBL] [Abstract][Full Text] [Related]
4. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis. Chini CC; Grande JP; Chini EN; Dousa TP J Biol Chem; 1997 Apr; 272(15):9854-9. PubMed ID: 9092521 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Ko WC; Shih CM; Lai YH; Chen JH; Huang HL Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679 [TBL] [Abstract][Full Text] [Related]
6. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV. Tsuboi Y; Shankland SJ; Grande JP; Walker HJ; Johnson RJ; Dousa TP J Clin Invest; 1996 Jul; 98(2):262-70. PubMed ID: 8755633 [TBL] [Abstract][Full Text] [Related]
7. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456 [TBL] [Abstract][Full Text] [Related]
8. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV. Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of cyclic nucleotide phosphodiesterase isozymes during culture of aortic endothelial cells. Ashikaga T; Strada SJ; Thompson WJ Biochem Pharmacol; 1997 Nov; 54(10):1071-9. PubMed ID: 9464449 [TBL] [Abstract][Full Text] [Related]
11. Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus. Homma S; Gapstur SM; Coffey A; Valtin H; Dousa TP Am J Physiol; 1991 Aug; 261(2 Pt 2):F345-53. PubMed ID: 1652209 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells. Matousovic K; Grande JP; Chini CC; Chini EN; Dousa TP J Clin Invest; 1995 Jul; 96(1):401-10. PubMed ID: 7615811 [TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase inhibitors in airways disease. Fan Chung K Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289 [TBL] [Abstract][Full Text] [Related]
14. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant. Erdogan S; Houslay MD Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416 [TBL] [Abstract][Full Text] [Related]
15. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord. de Vente J; Markerink-van Ittersum M; Vles JS J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445 [TBL] [Abstract][Full Text] [Related]
16. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis. Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4. Cheng J; Thompson MA; Walker HJ; Gray CE; Diaz Encarnacion MM; Warner GM; Grande JP Am J Physiol Renal Physiol; 2004 Nov; 287(5):F940-53. PubMed ID: 15280158 [TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation. Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]